Caffeine-potentiated chemo enhances survival ratesTreatment helps in osteosarcoma, particularly in young patients Canadian usage of clopidogrel following hospitalization falls short Vimovo: first NSAID–PPI combo now available in Canada AstraZeneca introducing first fixed-dose combination product containing a nonsteroidal anti-inflammatory drug and proton pump inhibitor. Canada could learn from Kenyan HIV texting study Canadian researcher says approach will also be assessed in British Columbia among low-income patients with HIV or TB Pharmetics recalls OTC products Pharmetics Inc. is voluntarily recalling selected lots of six OTC drugs from the Canadian market. New drug offers hope for triple-negative disease The new theory of (fee) relativity In Ontario, GPs are more comfortable. Other sections now have concerns but (mostly) accept the new process Canada should follow U.S. in using diabetes test Hemoglobin A1c test catches dysglycemia earlier than glucose test Sustained-release lithium back on the market AA Pharma introducing Lithmax (lithium carbonate 300 mg sustained-release tablets). CPhA, Aglukkaq hold first meeting First Previous 1083 1084 1085 1086 1087 Next Last
